William Ringo

William Ringo

Director/Board Member at
Marcadia Biotech, Inc.

Net worth: 57 115 $ as of 30/05/2026

80 year
Health Technology
Finance
Health Services

Profile

William R.
Ringo
is currently Director at Marcadia Biotech, Inc., Non-Executive Director at Atlantic Healthcare Plc since 2017, Director at Indiana University Health Foundation, Inc., Director at Encore Retail GP LLC since 2014, Director at Kovina Therapeutics, Inc. since 2021, and Venture Partner at InCube Venture Partners LLC.
Former roles include President & Chief Executive Officer at Abgenix, Inc. from 2004 to 2006, Non-Executive Chairman & Chief Executive Officer at InterMune, Inc. in 2003, Chairman at Community Health Systems, Inc. from 1994 to 2002, Chairman at Five Prime Therapeutics, Inc. from 2020 to 2021, Chairman at Hyperion Therapeutics, Inc., Chairman at Health Systems, Inc., Chairman at Assembly Biosciences, Inc. from 2015 to 2026, Chairman at Faeth Therapeutics, Inc. from 2022 to 2025, Director at Encysive Pharmaceuticals, Inc. from 2001 to 2007, Director at La Jolla Pharmaceutical Co., Independent Director at Onyx Pharmaceuticals, Inc. from 2011 to 2013, Director at Praecis Pharmaceuticals, Inc., Director at Allos Therapeutics, Inc. from 2007 to 2008, Independent Director at Sangamo Therapeutics, Inc. from 2016 to 2018, Director at Inspire Pharmaceuticals, Inc. from 2001 to 2007, Director at Alvine Pharmaceuticals, Inc., Independent Director at Mirati Therapeutics, Inc. from 2014 to 2016, Director at BioCrossroads, Independent Director at Immune Design Corp.
from 2014 to 2019, Independent Director at Dermira, Inc. from 2014 to 2020, President-Infectious Diseases Business Unit at Eli Lilly & Co. from 1973 to 2001, Senior VP-Strategy & Business Development at Pfizer Inc. from 2008 to 2010, Board Member at Portola Pharmaceuticals LLC from 2006 to 2009, Executive Partner at Sofinnova Investments, Inc. from 2010 to 2011, and Vice President-Sales & Marketing at US Pharmaceuticals, Inc. Education includes undergraduate and MBA degrees from the University of Dayton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/04/2026 1,455 ( 0.01% ) 40 245 $ 30/05/2026
20/05/2025 798 ( 0% ) 16 870 $ 30/05/2026

William Ringo active positions

CompaniesPositionStart
Director/Board Member 27/04/2011
Private Equity Investor -
Encore Retail GP LLC
Director/Board Member 19/03/2014
Director/Board Member 21/05/2017
Director/Board Member -
Director/Board Member 31/05/2021

Former positions of William Ringo

CompaniesPositionEnd
ASSEMBLY BIOSCIENCES, INC. Chairman 03/06/2026
FAETH THERAPEUTICS, INC. Chairman 01/01/2025
FIVE PRIME THERAPEUTICS, INC. Chief Executive Officer 12/04/2020
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of William Ringo's experience

Training of William Ringo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

32

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Finance

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Encore Retail GP LLC

Health Technology

Health Technology

Commercial Services